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SYNOPSIS

The thesis entitled “Design and Synthesis of New Pyrrolo[2,1-c][1,4]benzodiazepine Hybrids as DNA Interactive Antitumour Agents“ has been divided into four chapters. Chapter I gives the general introduction about cancer chemotherapy, covalent, non-covalent interactions of drug-DNA, particularly of pyrrolo[2,1-c][1,4]benzodiazepine antitumour antibiotics and objectives of the present work. Chapter II comprises of two sections; section A consists of the design, synthesis and DNA binding ability of novel anthraquinone-pyrrolo[2,1-c][1,4]benzodiazepine hybrids and their activity. While section B describes the design and synthesis of a first example of bifunctional PBDs with an intercalater and their biological activity. Chapter III is also divided into two sections; section A describes the synthesis, DNA binding affinity and in vitro anticancer activity of a series of pyrrolobenzodiazepine hybrids in which DC-81 has been linked to naphthalimide through piperazine moiety comprising of different alkyl chain lengths. Section B of chapter III describes the design, synthesis and biological activity of novel fluorenone-, and flavone-PBD hybrids. Chapter IV describes the development of a new methodology for the protection of carbonyls as thioacetals, its application in the synthesis of novel podophyllotoxin-PBD hybrids and their in vitro cytotoxicity.

Chapter I: General introduction

Cancer is a disease where cells grow and divide in an uncontrolled manner. The four types of treatment for cancer are surgery, radiation, chemotherapy and biological therapy. A major advantage of chemotherapy is its ability to treat cancer cells that have metastasized (spread) to other parts of the body, whereas surgery and radiation therapy are used to treat localized cancers. The major categories of chemotherapeutic agents are antitumour antibiotics, DNA topoisomerase I and II inhibitors, DNA interactive agents and other miscellaneous agents. Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are a well known class of antibiotics. PBDs have potential as regulators of gene expression with possible therapeutic application in the treatment of genetic disorders including cancer and as probes and tools for use in molecular biology.
The pyrrolo[2,1-c][1,4]benzodiazepine (PBD) class of antitumour antibiotics are derived from various Streptomyces species. Lemgruber et al described the first PBD antitumour antibiotic anthramycin in 1968 and since then a number of compounds have been developed based on PBD ring system.  These compounds exert their biological activity by covalent binding to the N2 of guanine in the minor groove of DNA through the imine or imine equivalent functionality at N10-C11 of PBD. These molecules have a right-handed twist, which provides the appropriate three dimensional shape for the isohelicity with the minor groove of B-form DNA leading to a snug fit at the binding site. 





Chapter II-Section A: Design, synthesis and biological evaluation of novel anthraquinone-pyrrolo[2,1-c][1,4]benzodiazepine hybrids

Recently, there has been growing interest in modifying and extending the recognition patterns of DNA binding ligands. Pyrrolo[2,1-c][1,4]benzodiazepine antitumour antibiotics bind covalently to the N2 of guanine in the minor groove of DNA. In the past few years, several PBD analogues have been designed and synthesized with the aim of finding related compounds showing better antitumour activity. The PBDs have been used as a scaffold to attach EDTA, epoxide, (+)-Cyclopropapyrroloindole and Cyclopropapylbenzindole moieties leading to novel unsymmetrical hybrids of PBD, which have exhibited novel sequence selective DNA cleaving and cross-linking properties.
Anthracenediones represent an important class of intercalating antitumour compounds. Mitoxantrone, which is the lead compound in this series is routinely used in clinic for the treatment of certain hematological malignancies, as well as ovarian and breast cancers.
The objective of the present work is to combine the features of both intercalating and DNA binding properties in the same molecule. Therefore, it has been considered of interest to couple anthraquinone to the C8-position of the PBD through its amino functionality. In the present chapter the synthesis, DNA binding affinity and in vitro cytotoxicity of the novel anthraquinone-PBD hybrids have been described. 
	Synthesis of these novel anthraquinone-PBD hybrids has been carried out by employing N-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-1-bromo-alkanamide (1a-b) as one of the precursors, which has been obtained by the reaction of an appropriate acid chloride with 1-aminoanthraquinone (Scheme-1). 
	The other precursor (2S)-N-(4-hydroxy-5-methoxy-2-nitrobenzoyl)pyrro-lidine-2-carboxaldehyde diethyl thioacetal 9 has been prepared by employing commercially available vanillin. Oxidation of vanillin followed by esterification employing literature method provides vanillin methyl ester 2. This on benzylation gives 3, which upon nitration followed by ester hydrolysis affords 5. L-Proline methyl ester has been coupled with 5 to give the nitro ester 6. This nitro ester upon treatment with DIBAL-H followed by protection of aldehyde with ethanethiol gives diethyl thioacetal 8. This upon debenzylation provides the compound 9. This nitrothioacetal has been coupled with N-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-1-bromo-alkanamide (1a-b) to give 10a-b. This nitrothioacetal has been reduced to give 11a-b. The deprotection of the thioacetal group afforded the desired compounds 12a-b (Scheme 2).





Compounds 12a-b have been evaluated for their in vitro cytotoxicity in selected human cancer cell lines of colon (HT-29, HCT-15), lung (A-549, HOP-62) and cervix (SiHa) origin. Compounds 12a and 12b exhibit significant cytotoxicity against some of the cancer cell lines. Compound 12a suppresses HT-29 and HCT-15 cell growth by 68% and 59% respectively. It is inhibiting HOP-62 cell growth by 74%. Compound 12b suppressing HT-29 and HCT-15 cell growth by 73% and 61%. It is also inhibiting A-549 and HOP-62 cell growth by 56% and 73%. 
The DNA binding affinity of these novel PBD hybrids has been evaluated through thermal denaturation studies with duplex-form of calf thymus DNA (CT-DNA). Melting studies show that these compounds stabilize the thermal helix to coil transition of the CT-DNA efficiently. In this assay, compound 12a has melting temperature of 9.1 C after incubation for 18 h at 37 C. Compound 12b elevates the melting temperature of CT-DNA by 5.2 C after incubation for 18 h. On the other hand, the naturally occurring DC-81 exhibits a ∆Tm of 0.7 C. Thus demonstrating that these PBD hybrids have significant DNA binding ability.

Chapter II-Section B: Design, synthesis and biological activity of novel bifunctional PBDs with intercalating anthraquinone

The cytotoxicity and antitumour activity of PBDs are attributed to their ability to form covalent adducts. PBD monomers span three base pairs with a preference for Pu-G-Pu motifs (where Pu = purine, G = guanine).  In an attempt to extend the number of base pairs spanned by these molecules, PBD dimers have been synthesized, with the hope that enhanced sequence selectivity might increase selectivity for tumour cells.
Since, Suggs and coworkers have reported the first PBD dimer comprising of two PBD units joined through their A-C7/A-C7’ positions, a number of PBD dimers have been designed and synthesized that exhibited varying degree of cytotoxicity and DNA cross-linking activity. These PBD dimers have been joined through different positions A-C8/A-C8’, C-C2/C-C2’, A-C8/C-C2’. Among these, A-C8/A-C8’ linked PBD dimers have shown promising cytotoxicity and efficient cross-linking properties. Thurston and coworkers synthesized A-C8/A-C8’ alkane diyldioxy bridged PBD dimers (DSB-120) and C2/C2’ exo-unsaturated PBD dimer (SJG-136) which span six base pairs of DNA and exhibit high DNA binding affinity and antitumour activity. 
The main objective of this work is to synthesize the bifunctional PBDs with an intercalater to enhance sequence selectivity and anticancer activity. Therefore, the synthesis of new PBD dimers in which two PBD units have been joined to the 1 and 4 positions of anthraquinone through their A-C8 positions via alkane diyldioxy bridge with linkers of varying lengths has been carried out. 
Synthesis of these novel PBD hybrids has been carried out by employing 1,4-bis-(n-bromoalkyloxy)anthracene-9,10-diones (13a-c) as one of the precursors, which have been obtained by etherification of 1,4-dihydroxy anthraquinone with dibromoalkanes. The other precursor (2S)-N-[4-hydroxy-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carboxaldehyde diethyl thioacetal (9) has been prepared as described in section-A. Compounds 13a-c have been coupled with 9 to give 1,4-bis-{n-[(2S)-N-(4-oxy-5-methoxy-2-nitrobenzoyl)-pyrrolidine-2-carboxaldehyde diethyl thioacetal]alkyloxy}anthracene-9,10-diones (14a-c). These anthraquinone coupled nitro thioacetal intermediates 14a-c have been efficiently reduced to afford the corresponding amino thioacetals 15a-c. Deprotection of the thioacetal group afforded the desired bifunctional PBDs with an intercalating anthraquinone moiety in compounds 16a-c (Scheme 3).  



	Compounds have been evaluated for their in vitro cytotoxicity in selected human cancer cell lines of colon (Colo205), lung (HOP-62), prostate (PC3) and cervix (SiHa) origin. Compound 16a has promising cytotoxicity in Colo205 and SiHa cell lines. Compound 16b has not shown significant cytotoxicity. Compound 16c has potent cytotoxicity in Colo205, HOP-62, PC3 and SiHa cell lines.

Chapter III-Section A: Synthesis, DNA binding affinity and in vitro anticancer activity of naphthalimide-pyrrolo[2,1-c][1,4]benzodiazepine hybrids

Cancer chemotherapy continues to be an important research avenue. Complex structures built out of groove binders linked to other moieties which interact with the DNA via intercalation or groove interactions or molecules which cleave DNA, are of interest in terms of inter alia. These compounds are capable of recognizing heterogeneous DNA sequences.
Many drugs that possess chemotherapeutic activity intercalate with DNA.  The orientation in the geometry of the limited drug-DNA complexes has been studied using X-ray diffraction, NMR spectroscopy and traditional solution methods. It has also been shown that a wide variety of planar ring systems can intercalate with DNA to exert their antitumour activity. 
In the present work, the design and synthesis of new PBD hybrids in which naphthalimides have been linked to PBD through alkyl piperazine moiety side armed by identical or mixed alkane chain spacers has been carried out. This study is with an objective to improve the lipophilicity, antitumour activity and DNA sequence specificity.
The synthesis of these new PBD hybrids has been carried out by employing piperazine linked naphthalimides 20a-c as one of the precursors. These have been obtained by alkylation of naphthalimide with dibromo compounds followed by coupling with N-boc piperazine and deprotection of boc with trifluoroacetic acid (Scheme 4).



Synthesis of the other precursor (2S)-N-[4-(n-bromoalkyloxy)-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carboxaldehyde diethyl thioacetal 25a-c has been carried out by employing the commercially available vanillin. Oxidation of vanillin followed by esterification employing literature methods provides the vanillin methyl ester (21). The mono alkylation of 21 has been achieved by using three molar equivalents of the dibromo alkanes. Nitration of 22a-c followed by ester hydrolysis and coupling of (2S)-pyrrolidine-2-carboxaldehyde diethyl thioaetal affords 25a-c. This nitro thioacetal has been coupled with 2-[n’-(piperazine-1-yl)alkyl]benz[de]isoquinoline-1,3-dione (20a-c) to give C8-linked naphthalimide nitro thioacetal 26a-e. This compound has been efficiently reduced by employing SnCl2.2H2O to afford the corresponding amino thioacetal. Deprotection of the thioacetal group with HgCl2 and CaCO3 afforded the desired naphthalimide-PBD hybrids 28a-e (Scheme 5).



Compounds have been evaluated for their in vitro cytotoxicity in selected human cancer cell lines of colon (HT-29, HCT-15), lung (A-549, HOP-62) and cervix (SiHa) origin. These compounds exhibit potent cytotoxicity. These compounds exhibit more than 75% inhibition even at 10-6 mol/L concentration in some of the cell lines. Compound 28b suppresses HT-29 and HOP-62 cell growth by 91% and 72% while compound 28c suppressing HT-29 and HOP-62 cell growth by 80% and 86% at 10-6 mol/L concentration. Compound 28d is inhibiting HT-29 cell growth by 63% and compound 28e inhibiting HT-29 and HOP-62 cell growth by 67% and 80% at the same concentration. 
The DNA binding affinity of these novel PBD hybrids has been evaluated through thermal denaturation studies with duplex-form of calf thymus DNA (CT-DNA). The results show that these compounds stabilize the thermal helix to coil transition of CT-DNA duplex more efficiently. There is an increase in the melting temperature when incubation time is increased from 0 to 18 h at 37 C. Compounds 28a and 28c elevate the helix melting temperature of CT-DNA by 22.7 C and 23.9 C respectively after incubation for 18 h at 37 C. Compounds 28d and 28e have shown a Tm of 12.9 C and 20.8 C. In this series, compound 28b has shown highest Tm value and it is increasing the helix-melting temperature by 26.5 C. In the same experiment, the naturally occurring DC-81 exhibits a ΔTm of 0.7 C and its dimer (DSB-120) gives a ΔTm of 15.4 C. This demonstrates that these new PBD hybrids have remarkable DNA binding affinity.

Chapter III-Section B: Synthesis and biological activity of novel fluorenone- and flavone-pyrrolo[2,1-c][1,4]benzodiazepine hybrids 

The biological activity of certain low molecular weight compounds appears to be related with their mode and specificity of interaction with particular DNA sequences. In the search of antitumour compounds with improved biological activity, an approach of hybrid ligands combining two modes of binding to DNA has been developed. Coupling of a polyaromatic heterocyclic to an addressing molecule does not only provide extra strength of binding but can also influence the sequence selectivity of the conjugate. With such hybrid molecules, it has been demonstrated that DNA is able to accept two types of binding in close proximity, despite their unique distortions. Furthermore, the length and flexibility of the spacer arms in conjugates seems to be critical for optimal positioning of both parts of the molecule. In view of the importance of the conjugates, synthesis of fluorenone- and flavone-PBD conjugates has been carried out to improve DNA binding ability and anticancer activity.
Synthesis of these novel hybrids has been carried out by employing (2S)-N-[4-(n-bromoalkyloxy)-5-methoxy-2-nitrobenzoyl]-pyrrolidine-2-carboxaldehy-de diethyl thioacetal (25b-d) as a precursor. This nitro thioacetal 25b-d has been coupled with 2-hydroxy fluorenone or 6-hydroxy flavone to give 29a-f. This intermediate has been reduced with SnCl2.2H2O to give amino thioacetal 30a-f. The deprotection of the thioacetal group afforded the desired compounds 31a-f (Scheme 6).


The DNA binding affinity of these novel PBD hybrids has been evaluated through thermal denaturation studies with duplex-form of calf thymus DNA (CT-DNA). In fluorenone series, compound 31a has shown a ΔTm of 6.1 C while compounds 31b and 31c elevate the helix melting temperature by 3.8 C and 3.9 C after incubation for 18 h. In flavone series, compound 31d has shown melting temperature of 3.8 C at 0 h and the melting temperature increases to 6.2 C after incubation for 18 h at 37 C. Compounds 31e and 31f elevate the helix melting temperature of the CT-DNA by 1.8 C and 2.6 C after incubation for 18 h. 
Compounds have been evaluated for their in vitro cytotoxicity in selected human cancer cell lines of colon (HT-29, HCT-15), lung (A-549, HOP-62) and cervix (SiHa) origin. Compound 31d has a strong effect to HT-29, HCT-15 and HOP-62 cell lines. Compound 31e has not shown any significant cytotoxicity. Compound 31f is suppressing HCT-15 and A-549 cell growth by 69% and 63%.

Chapter IV: Synthesis and in vitro cytotoxicity of novel podophyllotoxin-pyrrolo[2,1-c][1,4]benzodiazepine hybrids

The protection of carbonyl groups as acetals and thioacetals is most commonly used as an important synthetic technique in the course of preparation of many organic compounds including multifunctional complex molecules. Thioacetals are comparably more stable than the corresponding acetals under acidic conditions and are useful in organic synthesis as acyl carbanion equivalents in carbon-carbon bond forming reactions. Many of the reported methods suffer from some disadvantages.  The present chapter describes a simple and convenient method for the protection of aldehydes as thioacetals using Cu(BF4)2.xH2O under solvent-free conditions. The present chapter also describes the application of this methodology in the synthesis of novel podophyllotoxin-PBD hybrids and their in vitro anticancer activity.
Various aldehydes have been subjected to thioacetal formation by the treatment of carbonyl compound with ethanethiol under the catalytic influence of 5 mol% Cu(BF4)2.xH2O. 



	Synthesis of these novel podophyllotoxin-PBD hybrids has been carried out by employing (2S)-N-[4-benzyloxy-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carbox-aldehyde as one of the precursors, which has been obtained as described in chapter II. Protection of this aldehyde with ethanethiol in presence of Cu(BF4)2.xH2O afforded diethyl thioacetal 32. This upon debenzylation provides the compound (2S)-N-[4-hydroxy-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carboxaldehyde diethyl thioacetal (33). Etherification of compound 33 by methyl bromoalkanoate provides 34a-b. Basic hydrolysis of these esters gives the desired precursor acids 35a-b. The other precursor 4’-O-demethyl-4-amino-4-deoxy podophyllotoxin has been prepared by literature method. Amidation of this with acid 35a-b in presence of EDCI/HOBt affords the corresponding podophyllotoxin coupled nitro thioacetal intermediates 36a-b. This upon reduction affords 37a-b. The deprotection of the thioacetal group using HgCl2/CaCO3 resulted in the formation of the desired podophyllotoxin linked PBD hybrids 38a-b (Scheme 8).
Compounds 38a-b have been evaluated for their in vitro cytotoxicity in a panel of six human cancer cell lines. Compound 38a exhibit GI50 values in the range of 9.5-38.7 mM and GI50 values of compound 38b is 13.7-36.6 mM.
	In conclusion, the thesis describes the design, synthesis and biological activity of novel pyrrolo[2,1-c][1,4]benzodiazepine analogues with the potential to develop as anticancer agents.
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